Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.07 CAD
Change Today 0.00 / 0.00%
Volume 0.0
IBT On Other Exchanges
Symbol
Exchange
Stuttgart
OTC US
As of 12:40 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

ibex technologies inc (IBT) Snapshot

Open
C$0.07
Previous Close
C$0.07
Day High
C$0.07
Day Low
C$0.07
52 Week High
02/4/15 - C$0.11
52 Week Low
08/13/14 - C$0.05
Market Cap
1.6M
Average Volume 10 Days
18.3K
EPS TTM
C$0.04
Shares Outstanding
24.7M
EX-Date
01/9/86
P/E TM
1.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for IBEX TECHNOLOGIES INC (IBT)

Related News

No related news articles were found.

ibex technologies inc (IBT) Related Businessweek News

No Related Businessweek News Found

ibex technologies inc (IBT) Details

IBEX Technologies Inc., through its subsidiaries, manufactures and markets proteins for biomedical use. The company produces a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B. It also manufactures and markets a series of arthritis assays, which are used in osteoarthritis research; a series of arthritis biomarkers; and diagnostic products. The company sells its products in Canada, the United States, Europe, and Other countries. IBEX Technologies Inc. is based in Montreal, Canada.

ibex technologies inc (IBT) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: C$255.4K
Director of Finance and Secretary
Total Annual Compensation: C$106.2K
Compensation as of Fiscal Year 2014.

ibex technologies inc (IBT) Key Developments

IBEX Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2015

IBEX Technologies, Inc. reported earnings results for the third quarter and nine months ended April 30, 2015. For the quarter, the company reported sales totaled CAD 892,969 compared to CAD 1,140,228 in the same period of the prior year. The company sustained a net loss of CAD 288,538, as compared to net earnings of CAD 148,844 in the year ago period. This loss can be primarily traced to the CAD 247,259 reduction in sales. Sales for the nine months ended April 30, 2015 totaled CAD 2,241,768 compared to CAD 2,941,351 the same period of the prior year. The company recorded a net loss of CAD 720,874 compared to a net loss of CAD 258,097 for the same period a year ago. This net loss can be primarily traced to the reduction in sales revenue. Loss before interest, tax, depreciation & amortization was CAD 426,123 compared to earnings before interest, tax, depreciation &amortization of CAD 68,367 a year ago.

IBEX Technologies, Inc. Reports Earnings Results for the Second Quarter Ended January 31, 2015

IBEX Technologies, Inc. reported earnings results for the second quarter ended January 31, 2015. For the quarter, the company’s net loss per share was CAD 0.01 against CAD 0.00 for same period a year ago.

IBEX Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2015

IBEX Technologies, Inc. reported earnings results for the second quarter and six months ended January 31, 2015. For the quarter, the company reported sales of CAD 721,352 compared to CAD 922,007 in the same period of the prior year. The company sustained a net loss of CAD 178,628, as compared to a net loss of CAD 2,922 in the year ago period. This loss can be primarily traced to the CAD 200,655 reduction in sales. Losses were incurred in both the IBEX Pharma and the BRP subsidiaries. For the six months, the company reported sales of CAD 1,348,799 compared to CAD 1,801,123 the same period of the prior year. The company recorded a net loss of CAD 432,336 compared to a net loss of CAD 406,941 for the same period a year ago. This net loss can be traced to the reduction in sales revenue. Loss per share was CAD 0.02 against CAD 0.02 a year ago. Loss before interest, tax, depreciation & amortization was CAD 235,489 against CAD 184,603 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IBT:CN C$0.07 CAD 0.00

IBT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IBT.
View Industry Companies
 

Industry Analysis

IBT

Industry Average

Valuation IBT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IBEX TECHNOLOGIES INC, please visit www.ibex.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.